Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance (Q64123041)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance |
clinical trial |
Statements
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance (English)
0 references
6 July 2016
0 references
31 July 2024
0 references
43
0 references
18 year
0 references
60 year
0 references